CLINICAL ROLE -
Early Identification of Alzheimer Disease Is Key
Tau protein, plaque, and brain waves maybe the solutions to treating the progressive condition.
Current Good Manufacturing Practices Are Reliable Safeguard
Properly implemented CGMP should not be seen as a regulatory burden but a remedy to poorly compounded drugs.
340B Program Helps Reduce Health Care Disparities
Drug manufacturers participating in Medicaid offer lower prices, stretching resources and providing comprehensive services to more patients.
Brukinsa From BeiGene, Ltd
The FDA has approved zanubrutinib (Brukinsa, BeiGene) for the treatment of adults with Waldenström macroglobulinemia (WM).
Therapeutics Treat Patients Who Test Positive for COVID-19
Monoclonal antibodies and emerging agents may avert severe illness, especially for high-risk individuals.
FDA Approves Newest Antibody-Drug Conjugate for Cervical Cancer
Tisotumab vedotin-tftv is used as antitumor therapy for patients with disease progression during or after chemotherapy.
Disparities in Chronic Disease Outcomes Require Solutions
Finding ways to eliminate barriers to care helps narrow the gap.
Where Have All the Workers Gone?
Staffing shortage hits technician ranks hardest, putting additional pressure on pharmacists.
